Adoption of Direct-to-Consumer Laboratory Testing amid Covid-19 Pandemic

The Europe direct-to-consumer laboratory testing market witnessed an increasing demand due to consumer awareness in European countries. The increasing prevalence of infectious diseases post-pandemic is also driving the growth of the Europe direct-to-consumer laboratory testing market. Advancements in healthcare and adoption of direct-to-consumer laboratory testing methods are due to the rapidly spreading coronavirus in the European countries. Companies in the Europe direct-to-consumer laboratory testing market are focused on providing their services to cater to the increasing demand for consumer-driven laboratory testing procedures. These companies are striving to grab lucrative revenue opportunities by conducting rapid testing outside clinics and hospitals. Market players are entering into mergers & agreements with contract manufacturers to develop necessary testing kits that can be directly used by consumers.

europe direct to consumer laboratory testing market infographic

Request a sample to get extensive insights into the Direct-to-Consumer Laboratory Testing Market

Popularity Due to Increasing Consumer Awareness in European Countries

The Europe direct-to-consumer laboratory testing market is expected to surpass US$ 7.8 Bn by 2031. In countries such as Spain, Germany, France, and Italy, consumers are more aware of the advantages of direct-to-consumer laboratory tests over conventional laboratory testing methods. Increasing demand for disease risk assessment tests, COVID-19 tests, pregnancy tests, and various other nutrigenetics tests are boosting the Europe direct-to-consumer laboratory testing market. Governments are investing in promoting awareness and importance of such testing methods to cater to the increasing demand from consumers. The rising presence of companies and market players to provide these convenience services also fuels the Europe direct-to-consumer laboratory testing market.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Increasing Geriatric Population and Growing Prevalence of Infectious Diseases

With changing lifestyles and increasing prevalence of infectious diseases such as coronavirus, HIV, Influenza, etc., there is a continuous demand for rapid diagnosis and treatment. The rise in the number of lifestyle diseases such as diabetes, heart diseases, obesity, hypertension, cancer, etc. has augmented the demand for convenient diagnostic tests. Rapid test procedures, availability of test kits, and accurate results can prevent the spreading of such diseases. People are adopting innovative healthcare practices with rapid advancements in technologies. The increasing geriatric population in Europe is responsible for the increasing demand for convenient direct-to-consumer laboratory tests (DTC), which, in turn, boost the Europe direct-to-consumer laboratory testing market growth. Ongoing research & development in the direct-to-consumer procedures to perform variety of tests is likely to drive market in Europe.

Rapid Advancements in Healthcare, Test Confidentiality, and Convenience

Due to rapid advancements in the healthcare industry, acceptance of telehealth practices, and digitalization, people are becoming smarter to take advantage of recent trends and technologies that are being used in healthcare. Direct-to-consumer laboratory tests allow consumers to save their time and efforts to visit medical professionals for disease diagnosis. Direct-to-consumer laboratory tests can be ordered online from laboratory and test results are used to monitor health condition and to find out unknown medical disorders. This is the efficient way to involve consumer in the clinical diagnosis process; hence, they are called consumer-focused. The increasing popularity of such tests is due to its confidentiality and convenience where consumer need not have to wait for test results and tiring procedure to meet healthcare professionals. This factor contributes to the growth of the Europe direct-to-consumer laboratory testing market.

europe direct to consumer laboratory testing market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Direct-to-Consumer Laboratory Testing Market

Analysts’ Viewpoint

Increased awareness and genetic research & development activities initiated by various countries are driving the market in the region. The acceptance of modern technological practices introduced in the healthcare industry for the betterment of patients is also contributing to the Europe direct-to-consumer laboratory testing market growth. Consumer-driven testing is widely popular in European countries, due to its increased awareness, convenience, and accurate diagnosis of various health conditions. Increasing efforts of companies operating in the Europe direct-to-consumer laboratory testing market boost the demand for personalized healthcare services on a timely basis, where consumers can order test kits online and laboratory professionals delivers test results directly to the consumers without the involvement of health practitioners.

Europe Direct-to-Consumer Laboratory Testing Market: Overview

  • This report analyzes the current scenario and future prospects of the direct-to-consumer laboratory testing market in Europe. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces customers to seek personalized services and maximizes customer satisfaction.
  • The report includes an elaborate executive summary, which provides a snapshot of various segments and sub-segments of the direct-to-consumer laboratory testing market in Europe. It also provides information and data analysis of the direct-to-consumer laboratory testing market in Europe about segments based on test type, sample type, provider, and country.
  • The overview section of the report provides a detailed qualitative analysis of drivers, restraints, and opportunities that affect the direct-to-consumer laboratory testing market in Europe
  • The report includes company profiles, which provide information about their business, product portfolios, strategic overview, and competitive landscape in the direct-to-consumer laboratory testing market in Europe
  • The report on the direct-to-consumer laboratory testing market in Europe offers market attractiveness analysis of regions and segments
  • The last section of the report comprises quantitative and qualitative analyses on market share/position of key players operating in the direct-to-consumer laboratory testing market in Europe. It analyzes key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the direct-to-consumer laboratory testing market in Europe.

Europe Direct-to-Consumer Laboratory Testing Market: Key Segments

  • In terms of test type, the direct-to-consumer laboratory testing market in Europe has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men's health tests, women's health tests, pregnancy & prenatal screening, general health testing, and others. The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been categorized into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been segregated into diabetes testing, hypertension, and others.
  • Based on sample type, the direct-to-consumer laboratory testing market in Europe has been categorized into blood, saliva, urine, and others
  • In terms of provider, the direct-to-consumer laboratory testing market in Europe has been divided into hospitals, clinics, specialty labs, and diagnostic centers
  • Market size and forecast for each of these segments and sub-segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided from 2021 to 2031, considering 2020 as the base year, and 2017, 2018, and 2019 as historical years.

Europe Direct-to-Consumer Laboratory Testing Market: Regional Outlook

  • In terms of country, the direct-to-consumer laboratory testing market in Europe has been segmented into the U.K., Germany, Spain, Italy, France, and Rest of Europe
  • The direct-to-consumer laboratory testing market report provides size and forecast for each country/sub-region from 2017 to 2031. The CAGR for each of these countries/sub-region has also been provided for the forecast period from 2021 to 2031. The direct-to-consumer laboratory testing market study covers the competitive scenario in these regions.

Companies Covered in Europe Direct-to-Consumer Laboratory Testing Market Report

  • Key players in the direct-to-consumer laboratory testing market in Europe have been profiled based on attributes such as company overview, product portfolio, financial overview, strategic overview, recent developments, and competitive business strategies
  • Major companies profiled in the direct-to-consumer laboratory testing market report are
    • 23andMe, Inc.
    • Ancestry
    • CircleDNA
    • Eurofins Scientific
    • Family Tree DNA (Gene by Gene)
    • Laboratory Corporation of America Holdings
    • Living DNA Ltd.
    • Medichecks.com Ltd.
    • MyHeritage Ltd.
    • MyMedLab, Inc.
    • Quest Diagnostics Incorporated

Europe Direct-to-Consumer Laboratory Testing Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 603 Mn

Market Forecast Value in 2031

US$ 7.8 Bn

Growth Rate (CAGR)

26%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis at Europe as well as country level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key industry events, etc.

Competition Landscape

Market share analysis by company (2020)

Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports and Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy and Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
  • Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
  • Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers

Regions Covered

Europe

 

Germany

U.K.

France

Italy

Spain

Rest of Europe

Companies Profiled

23andMe, Inc.

Ancestry

CircleDNA

Eurofins Scientific

Family Tree DNA (Gene by Gene)

Laboratory Corporation of America Holdings

Living DNA Ltd.

Medichecks.com Ltd.

MyHeritage Ltd.

MyMedLab, Inc.

Quest Diagnostics Incorporated

Customization Scope

Available upon request

Pricing

Available upon request

Europe Direct-to-Consumer Laboratory Testing Market – Scope of Report

TMR’s report on the direct-to-consumer laboratory testing market in Europe studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the revenue of the direct-to-consumer laboratory testing market in Europe for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the direct-to-consumer laboratory testing market in Europe for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the direct-to-consumer laboratory testing market in Europe.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the direct-to-consumer laboratory testing market in Europe.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the direct-to-consumer laboratory testing market in Europe. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the direct-to-consumer laboratory testing market in Europe. The next section of the direct-to-consumer laboratory testing market report highlights the USPs such as key industrial events (licensing partnership/merger & acquisition), disease epidemiology by region/country, COVID-19 pandemic impact on industry (value chain and short/mid/long-term impact), and key success factors of top players operating in the direct-to-consumer laboratory testing market in Europe.

The report also delves into the competition landscape of the direct-to-consumer laboratory testing market in Europe. Key players operating in the direct-to-consumer laboratory testing market in Europe have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, strategic overview, and SWOT are some of the attributes of players in the direct-to-consumer laboratory testing market in Europe profiled in this report.

Key Questions Answered in Europe Direct-to-Consumer Laboratory Testing Market Report

  • What are the major drivers, restraints, and opportunities in the market?
  • What are the revenue share projections of key segments of the direct-to-consumer laboratory testing market in Europe during the forecast period?
  • Which segment is likely to lead the direct-to-consumer laboratory testing market in Europe in terms of revenue by 2031?
  • How technological developments are widening the scope for the direct-to-consumer laboratory testing market in Europe?
  • What is the market position of different companies operating in the direct-to-consumer laboratory testing market in in Europe?

Europe Direct-to-Consumer Laboratory Testing Market – Research Objectives and Research Approach

The comprehensive report on the direct-to-consumer laboratory testing market in Europe begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind the study and healthcare compliances laid down by accredited agencies in the purview of research in the direct-to-consumer laboratory testing market in Europe. It is followed by market introduction, market dynamics, and an overview of the direct-to-consumer laboratory testing market in Europe, which includes TMR analysis of market drivers, restraints, and opportunities affecting the growth of the direct-to-consumer laboratory testing market in Europe. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the direct-to-consumer laboratory testing market in Europe.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the direct-to-consumer laboratory testing market in in Europe in terms of test type, sample type, provider, and country. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investments in the direct-to-consumer laboratory testing market.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Europe Direct-to-Consumer Laboratory Testing Market – Segmentation

Test Type
  • Genetic Testing
    • Nutrigenetics Test
      • Weight Control
      • Lactose Intolerance
      • Others
    • Celiac Disease Test
    • Sports & Physical Activity Testing
    • Men's Health Tests
    • Women's Health Tests
    • Pregnancy & Prenatal Screening
    • General Health Testing
    • Others
  • Disease Risk Assessment Testing
    • Sexual Health Tests
      • HIV
      • Chlamydia
      • Others
    • Cancer Predisposition Tests
    • Others
  • CBC
  • Chronic Disease Testing
    • Diabetes Testing
    • Hypertension
    • Others
  • COVID-19 Testing
  • TSH Testing
  • Others
Sample Type
  • Blood
  • Saliva
  • Urine
  • Others
Provider
  • Hospitals
  • Clinics
  • Specialty Labs
  • Diagnostic Centers
Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Direct-to-Consumer Laboratory Testing Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Key Industrial Events (licensing partnerships/mergers & acquisitions)

    5.2. Disease Prevalence & Incidence Rate

    5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Sample Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Sample Type, 2017–2031

        6.3.1. Blood

        6.3.2. Urine

        6.3.3. Saliva

        6.3.4. Others

    6.4. Market Attractiveness Analysis, by Sample Type

7. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Test Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Test Type, 2017–2031

        7.3.1. Genetic Testing

            7.3.1.1. Nutrigenetics Test

                7.3.1.1.1. Weight Control

                7.3.1.1.2. Lactose Intolerance

                7.3.1.1.3. Others

            7.3.1.2. Celiac Disease Test

            7.3.1.3. Sports & Physical Activity Testing

            7.3.1.4. Men's Health Tests

            7.3.1.5. Women's Health Tests

            7.3.1.6. Pregnancy & Prenatal Screening Test

            7.3.1.7. General Health Testing

            7.3.1.8. Others

        7.3.2. Disease Risk Assessment Testing

            7.3.2.1. Sexual Health Tests

                7.3.2.1.1. HIV

                7.3.2.1.2. Chlamydia

                7.3.2.1.3. Others

            7.3.2.2. Cancer Predisposition Tests

            7.3.2.3. Others

        7.3.3. CBC

        7.3.4. Chronic Disease Testing

            7.3.4.1. Diabetes Testing

            7.3.4.2. Hypertension

            7.3.4.3. Others

        7.3.5. COVID-19 Testing

        7.3.6. TSH Testing

        7.3.7. Others

    7.4. Market Attractiveness Analysis, by Test Type

8. Europe Direct-to-Consumer Laboratory Testing Market Analysis and Forecast, by Provider

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Provider, 2017–2031

        8.3.1. Hospitals

        8.3.2. Clinics

        8.3.3. Speciality Labs

        8.3.4. Diagnostic Centres

    8.4. Market Attractiveness Analysis, by Provider

9. Germany Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Sample Type, 2017–2031

        9.2.1. Blood

        9.2.2. Urine

        9.2.3. Saliva

        9.2.4. Others

    9.3. Market Value Forecast, by Test Type, 2017–2031

        9.3.1. Genetic Testing

            9.3.1.1. Nutrigenetics Test

                9.3.1.1.1. Weight Control

                9.3.1.1.2. Lactose Intolerance

                9.3.1.1.3. Others

            9.3.1.2. Celiac Disease Test

            9.3.1.3. Sports & Physical Activity Testing

            9.3.1.4. Men's Health Tests

            9.3.1.5. Women's Health Tests

            9.3.1.6. Pregnancy & Prenatal Screening Test

            9.3.1.7. General Health Testing

            9.3.1.8. Others

        9.3.2. Disease Risk Assessment Testing

            9.3.2.1. Sexual Health Tests

                9.3.2.1.1. HIV

                9.3.2.1.2. Chlamydia

                9.3.2.1.3. Others

            9.3.2.2. Cancer Predisposition Tests

            9.3.2.3. Others

        9.3.3. CBC

        9.3.4. Chronic Disease Testing

            9.3.4.1. Diabetes Testing

            9.3.4.2. Hypertension

            9.3.4.3. Others

        9.3.5. COVID-19 Testing

        9.3.6. TSH Testing

        9.3.7. Others

    9.4. Market Value Forecast, by Provider, 2017–2031

        9.4.1. Hospitals

        9.4.2. Clinics

        9.4.3. Speciality Labs

        9.4.4. Diagnostic Centres

10. U.K. Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Sample Type, 2017–2031

        10.2.1. Blood

        10.2.2. Urine

        10.2.3. Saliva

        10.2.4. Others

    10.3. Market Value Forecast, by Test Type, 2017–2031

        10.3.1. Genetic Testing

            10.3.1.1. Nutrigenetics Test

                10.3.1.1.1. Weight Control

                10.3.1.1.2. Lactose Intolerance

                10.3.1.1.3. Others

            10.3.1.2. Celiac Disease Test

            10.3.1.3. Sports & Physical Activity Testing

            10.3.1.4. Men's Health Tests

            10.3.1.5. Women's Health Tests

            10.3.1.6. Pregnancy & Prenatal Screening Test

            10.3.1.7. General Health Testing

            10.3.1.8. Others

        10.3.2. Disease Risk Assessment Testing

            10.3.2.1. Sexual Health Tests

                10.3.2.1.1. HIV

                10.3.2.1.2. Chlamydia

                10.3.2.1.3. Others

            10.3.2.2. Cancer Predisposition Tests

            10.3.2.3. Others

            10.3.2.4. CBC

            10.3.2.5. Chronic Disease Testing

                10.3.2.5.1. Diabetes Testing

                10.3.2.5.2. Hypertension

                10.3.2.5.3. Others

            10.3.2.6. COVID-110 Testing

            10.3.2.7. TSH Testing

            10.3.2.8. Others

    10.4. Market Value Forecast, by Provider, 2017–2031

        10.4.1. Hospitals

        10.4.2. Clinics

        10.4.3. Speciality Labs

        10.4.4. Diagnostic Centres

11. France Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Sample Type, 2017–2031

        11.2.1. Blood

        11.2.2. Urine

        11.2.3. Saliva

        11.2.4. Others

    11.3. Market Value Forecast, by Test Type, 2017–2031

        11.3.1. Genetic Testing

            11.3.1.1. Nutrigenetics Test

                11.3.1.1.1. Weight Control

                11.3.1.1.2. Lactose Intolerance

                11.3.1.1.3. Others

            11.3.1.2. Celiac Disease Test

            11.3.1.3. Sports & Physical Activity Testing

            11.3.1.4. Men's Health Tests

            11.3.1.5. Women's Health Tests

            11.3.1.6. Pregnancy & Prenatal Screening Test

            11.3.1.7. General Health Testing

            11.3.1.8. Others

        11.3.2. Disease Risk Assessment Testing

            11.3.2.1. Sexual Health Tests

                11.3.2.1.1. HIV

                11.3.2.1.2. Chlamydia

                11.3.2.1.3. Others

            11.3.2.2. Cancer Predisposition Tests

            11.3.2.3. Others

        11.3.3. CBC

        11.3.4. Chronic Disease Testing

            11.3.4.1. Diabetes Testing

            11.3.4.2. Hypertension

            11.3.4.3. Others

        11.3.5. COVID-19 Testing

        11.3.6. TSH Testing

        11.3.7. Others

    11.4. Market Value Forecast, by Provider, 2017–2031

        11.4.1. Hospitals

        11.4.2. Clinics

        11.4.3. Speciality Labs

        11.4.4. Diagnostic Centres

12. Italy Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Sample Type, 2017–2031

        12.2.1. Blood

        12.2.2. Urine

        12.2.3. Saliva

        12.2.4. Others

    12.3. Market Value Forecast, by Test Type, 2017–2031

        12.3.1. Genetic Testing

            12.3.1.1. Nutrigenetics Test

                12.3.1.1.1. Weight Control

                12.3.1.1.2. Lactose Intolerance

                12.3.1.1.3. Others

            12.3.1.2. Celiac Disease Test

            12.3.1.3. Sports & Physical Activity Testing

            12.3.1.4. Men's Health Tests

            12.3.1.5. Women's Health Tests

            12.3.1.6. Pregnancy & Prenatal Screening Test

            12.3.1.7. General Health Testing

            12.3.1.8. Others

        12.3.2. Disease Risk Assessment Testing

            12.3.2.1. Sexual Health Tests

                12.3.2.1.1. HIV

                12.3.2.1.2. Chlamydia

                12.3.2.1.3. Others

            12.3.2.2. Cancer Predisposition Tests

            12.3.2.3. Others

        12.3.3. CBC

        12.3.4. Chronic Disease Testing

            12.3.4.1. Diabetes Testing

            12.3.4.2. Hypertension

            12.3.4.3. Others

        12.3.5. COVID-19 Testing

        12.3.6. TSH Testing

        12.3.7. Others

    12.4. Market Value Forecast, by Provider, 2017–2031

        12.4.1. Hospitals

        12.4.2. Clinics

        12.4.3. Speciality Labs

        12.4.4. Diagnostic Centres

13. Spain Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Sample Type, 2017–2031

        13.2.1. Blood

        13.2.2. Urine

        13.2.3. Saliva

        13.2.4. Others

    13.3. Market Value Forecast, by Test Type, 2017–2031

        13.3.1. Genetic Testing

            13.3.1.1. Nutrigenetics Test

                13.3.1.1.1. Weight Control

                13.3.1.1.2. Lactose Intolerance

                13.3.1.1.3. Others

            13.3.1.2. Celiac Disease Test

            13.3.1.3. Sports & Physical Activity Testing

            13.3.1.4. Men's Health Tests

            13.3.1.5. Women's Health Tests

            13.3.1.6. Pregnancy & Prenatal Screening Test

            13.3.1.7. General Health Testing

            13.3.1.8. Others

        13.3.2. Disease Risk Assessment Testing

            13.3.2.1. Sexual Health Tests

                13.3.2.1.1. HIV

                13.3.2.1.2. Chlamydia

                13.3.2.1.3. Others

            13.3.2.2. Cancer Predisposition Tests

            13.3.2.3. Others

        13.3.3. CBC

        13.3.4. Chronic Disease Testing

            13.3.4.1. Diabetes Testing

            13.3.4.2. Hypertension

            13.3.4.3. Others

        13.3.5. COVID-19 Testing

        13.3.6. TSH Testing

        13.3.7. Others

    13.4. Market Value Forecast, by Provider, 2017–2031

        13.4.1. Hospitals

        13.4.2. Clinics

        13.4.3. Speciality Labs

        13.4.4. Diagnostic Centres

14. Rest of Europe Countries Direct-to-Consumer Laboratory Testing Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Sample Type, 2017–2031

        14.2.1. Blood

        14.2.2. Urine

        14.2.3. Saliva

        14.2.4. Others

    14.3. Market Value Forecast, by Test Type, 2017–2031

        14.3.1. Genetic Testing

            14.3.1.1. Nutrigenetics Test

                14.3.1.1.1. Weight Control

                14.3.1.1.2. Lactose Intolerance

                14.3.1.1.3. Others

            14.3.1.2. Celiac Disease Test

            14.3.1.3. Sports & Physical Activity Testing

            14.3.1.4. Men's Health Tests

            14.3.1.5. Women's Health Tests

            14.3.1.6. Pregnancy & Prenatal Screening Test

            14.3.1.7. General Health Testing

            14.3.1.8. Others

        14.3.2. Disease Risk Assessment Testing

            14.3.2.1. Sexual Health Tests

                14.3.2.1.1. HIV

                14.3.2.1.2. Chlamydia

                14.3.2.1.3. Others

            14.3.2.2. Cancer Predisposition Tests

            14.3.2.3. Others

        14.3.3. CBC

        14.3.4. Chronic Disease Testing

            14.3.4.1. Diabetes Testing

            14.3.4.2. Hypertension

            14.3.4.3. Others

        14.3.5. COVID-19 Testing

        14.3.6. TSH Testing

        14.3.7. Others

    14.4. Market Value Forecast, by Provider, 2017–2031

        14.4.1. Hospitals

        14.4.2. Clinics

        14.4.3. Speciality Labs

        14.4.4. Diagnostic Centres

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Company Profiles

        15.2.1. 23andMe, Inc.

            15.2.1.1. Company Description

            15.2.1.2. Business Overview

            15.2.1.3. Strategic Overview

            15.2.1.4. SWOT Analysis

        15.2.2. Ancestry

            15.2.2.1. Company Description

            15.2.2.2. Business Overview

            15.2.2.3. SWOT Analysis

        15.2.3. CircleDNA

            15.2.3.1. Company Description

            15.2.3.2. Business Overview

            15.2.3.3. SWOT Analysis

        15.2.4. Eurofins Scientific

            15.2.4.1. Company Description

            15.2.4.2. Business Overview

            15.2.4.3. Financial Overview

            15.2.4.4. SWOT Analysis

        15.2.5. Family Tree DNA (Gene by Gene)

            15.2.5.1. Company Description

            15.2.5.2. Business Overview

            15.2.5.3. SWOT Analysis

        15.2.6. Laboratory Corporation of America Holdings

            15.2.6.1. Company Description

            15.2.6.2. Business Overview

            15.2.6.3. Financial Overview

            15.2.6.4. Strategic Overview

            15.2.6.5. SWOT Analysis

        15.2.7. Living DNA Ltd.

            15.2.7.1. Company Description

            15.2.7.2. Business Overview

            15.2.7.3. SWOT Analysis

        15.2.8. Medichecks.com Ltd.

            15.2.8.1. Company Description

            15.2.8.2. Business Overview

            15.2.8.3. SWOT Analysis

        15.2.9. MyHeritage Ltd.

            15.2.9.1. Company Description

            15.2.9.2. Business Overview

            15.2.9.3. SWOT Analysis

        15.2.10. MyMedLab, Inc.

            15.2.10.1. Company Description

            15.2.10.2. Business Overview

            15.2.10.3. SWOT Analysis

        15.2.11. Quest Diagnostics Incorporated

            15.2.11.1. Company Description

            15.2.11.2. Business Overview

            15.2.11.3. Financial Overview

            15.2.11.4. Strategic Overview

            15.2.11.5. SWOT Analysis

List of Tables

Table 01: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 02: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 07: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 08: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 09: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 10: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 11: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 12: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 13: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 14: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 15: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 16: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 17: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 18: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 19: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 20: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 21: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 22: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 23: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 24: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 25: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 26: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 27: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 28: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 29: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 30: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 31: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 32: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 33: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 34: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 35: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 36: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 37: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 38: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 39: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 40: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 41: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 42: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 43: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 44: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 45: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 46: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 47: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 48: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

Table 49: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sample Type, 2017–2031

Table 50: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2031

Table 51: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Genetic Testing, 2017–2031

Table 52: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Nutrigenetics Test, 2017–2031

Table 53: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Disease Risk Assessment Testing, 2017–2031

Table 54: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Sexual Health Tests, 2017–2031

Table 55: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Chronic Disease Testing, 2017–2031

Table 56: Rest of Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, by Provider, 2017–2031

List of Figures

Figure 01: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 02: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 03: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Blood, 2017–2031

Figure 04: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 05: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Urine, 2017–2031

Figure 06: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 07: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 08: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 09: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Genetic Testing, 2017–2031

Figure 10: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Disease Risk Assessment Testing, 2017–2031

Figure 11: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by CBC, 2017–2031

Figure 12: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Chronic Disease Testing, 2017–2031

Figure 13: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by COVID-19 Testing, 2017–2031

Figure 14: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by TSH Testing, 2017–2031

Figure 15: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Others, 2017–2031

Figure 16: Europe Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 17: Europe Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 18: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 19: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Clinics, 2017–2031

Figure 20: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Specialty Labs, 2017–2031

Figure 21: Europe Direct-to-Consumer Laboratory Testing Market Value (US$ Mn), by Diagnostic Centers, 2017–2031

Figure 22: Germany Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 23: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 24: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 25: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 26: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 27: Germany Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 28: Germany Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 29: U.K. Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 30: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 31: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 32: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 33: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 34: U.K. Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 35: U.K. Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 36: France Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 38: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 39: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 40: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 41: France Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 42: France Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 43: Italy Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 44: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 45: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 46: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 47: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 48: Italy Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 49: Italy Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Figure 50: Spain Direct-to-Consumer Laboratory Testing Market Value (US$ Mn) Forecast, 2017–2031

Figure 51: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Sample Type, 2020 and 2031

Figure 52: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Sample Type, 2021–2031

Figure 53: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Test Type, 2020 and 2031

Figure 54: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Test Type, 2021–2031

Figure 55: Spain Direct-to-Consumer Laboratory Testing Market Value Share Analysis, by Provider, 2020 and 2031

Figure 56: Spain Direct-to-Consumer Laboratory Testing Market Attractiveness Analysis, by Provider, 2021–2031

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Europe Direct To Consumer Laboratory Testing Market